Tom Williams Named Executive Vice President and CMO of BNSF
Tom Williams to succeed Steve Bobb as executive vice president and chief marketing officer. Jon Gabriel named group vice president. FORT WORTH, Texas–(BUSINESS... Read more.
BNSF Announces Leadership Changes in Transportation, Service Design and Marketing
Matt Garland, Katie Hower and Farah Lawler take on new roles effective September 1, 2024 FORT WORTH, Texas–(BUSINESS WIRE)–BNSF Railway Company (BNSF)... Read more.
Newrez Sweeps All Four Eligible Military Friendly® Awards for Second Consecutive Year
FORT WASHINGTON, Pa.–(BUSINESS WIRE)–Newrez LLC (“Newrez”), a leading national mortgage lender and servicer, is proud to announce for the second... Read more.
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Direct Digital Holdings, Inc. (DRCT)
BENSALEM, Pa.–(BUSINESS WIRE)–Law Offices of Howard G. Smith reminds investors of the upcoming July 22, 2024 deadline to file a lead plaintiff motion... Read more.
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fastly, Inc. (FSLY)
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming July 23, 2024 deadline to file a lead plaintiff... Read more.
Collins joins Church Mutual® Marketing team
MERRILL, Wis.–(BUSINESS WIRE)–Sarah J. Collins has joined Church Mutual Insurance Company, S.I. (a stock insurer)1 as assistant vice president – marketing.... Read more.
AKLI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akili, Inc. Is Fair to Shareholders
NEW YORK–(BUSINESS WIRE)–Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Akili, Inc. (NASDAQ: AKLI) to Virtual Therapeutics... Read more.
Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced the presentation of alisertib for the treatment... Read more.
PSC Partners Announces the First Patient Enrolled Into the WIND-PSC Study, a Global Prospective Cohort to Support the Development of New Treatments for Primary Sclerosing Cholangitis
WIND-PSC will enroll up to 2000 patients with primary sclerosing cholangitis (PSC) across North America and Europe Study designed in collaboration with top global... Read more.
Mythic Therapeutics Presents Initial Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study on MYTX-011 at the American Society of Clinical Oncology (ASCO) Annual Meeting
Preliminary profile supports development of MYTX-011 in multiple subsets of NSCLC WALTHAM, Mass.–(BUSINESS WIRE)–Mythic Therapeutics, a clinical-stage... Read more.